BH
Brad Hively (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in The Oncology Institute, Inc. (STLN). The largest single filing was $1.9M of STLN (298,853 sh × $6.51, as filed), executed Aug 21. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Aug 21
Filed Aug 24
Median ADV $10.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
STLN
The Oncology Institute, Inc.
STLN · 0 buys · 1 sell
1 filing
TOI
Starling Oncology Inc
TOI · 0 buys · 1 sell
1 filing
Recent filings
STLNSALE
The Oncology Institute, Inc.
View filing →
$1.9M298,853 sh × $6.51
Exec Aug 21
Filed Aug 24 · 5:11 PM ET TOISALE Starling Oncology Inc View filing → $5.7M
1,976,137 sh across 2 lots
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET